EFFECTS OF INTRAVITREAL INJECTION OF BEVACIZUMAB ON INFLAMMATORY CYTOKINES IN THE VITREOUS WITH PROLIFERATIVE DIABETIC RETINOPATHY

Angiofibrotic Response to Vascular Endothelial Growth Factor Inhibition in Diabetic Retinal Detachment

(2012) Elliott H. Sohn et al.   ARCHIVES OF OPHTHALMOLOGY

Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population

(2012) Mohsen Azimi-Nezhad et al.   CYTOKINE

Distinct types of tumors exhibit differential grade of inflammation and angiogenesis in mice

(2012) C.T.R. Viana et al.   MICROVASCULAR RESEARCH

Vascular Endothelial Growth Factor in Plasma and Vitreous Fluid of Patients with Proliferative Diabetic Retinopathy Patients after Intravitreal Injection of Bevacizumab

(2011) Yan Ma et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Reduction in Dose of Intravitreous Bevacizumab Before Vitrectomy for Proliferative Diabetic Retinopathy

(2011) Hidetaka Yamaji   ARCHIVES OF OPHTHALMOLOGY

A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy

(2011) L.-Q. Zhao et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion

(2011) Yukihiko Suzuki et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Inflammatory and Angiogenic Factors in the Aqueous Humor and the Relationship to Diabetic Retinopathy

(2010) In Kyung Oh et al.   CURRENT EYE RESEARCH

CORRELATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR WITH CHEMOKINES IN THE VITREOUS IN DIABETIC RETINOPATHY

(2010) YOSHIHIRO WAKABAYASHI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab

(2009) Kayako Matsuyama et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Vitreous Mediators after Intravitreal Bevacizumab or Triamcinolone Acetonide in Eyes with Proliferative Diabetic Retinopathy

(2009) Noboru Arimura et al.   OPHTHALMOLOGY

Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema

(2009) J. Fernando Arevalo et al.   OPHTHALMOLOGY

Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases

(2009) Takeru Yoshimura et al.   PLoS One

Comparative Therapy Evaluation of Intravitreal Bevacizumab and Triamcinolone Acetonide on Persistent Diffuse Diabetic Macular Edema

(2008) Masahiko Shimura et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Intravitreal Bevacizumab to Treat Iris Neovascularization and Neovascular Glaucoma Secondary to Ischemic Retinal Diseases in 41 Consecutive Cases

(2008) Taku Wakabayashi et al.   OPHTHALMOLOGY

PROINFLAMMATORY CYTOKINES AND ANGIOGENIC AND ANTI-ANGIOGENIC FACTORS IN VITREOUS OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY AND EALES’ DISEASE

(2008) PONNALAGU MURUGESWARI et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

LONG-TERM EFFECT OF INTRAVITREAL BEVACIZUMAB (AVASTIN) IN PATIENTS WITH CHRONIC DIFFUSE DIABETIC MACULAR EDEMA

(2008) DANIEL KOOK et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES